Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.
Saved in:
| Title: | Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma. |
|---|---|
| Authors: | Wu JT; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Nowak E; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Imamura J; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Leng J; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Shepard D; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Scott J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Nystrom L; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA., Mesko N; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, OH, USA., Burke ZDC; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. burkez@ccf.org.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org. |
| Source: | Current treatment options in oncology [Curr Treat Options Oncol] 2025 Oct; Vol. 26 (10), pp. 891-909. Date of Electronic Publication: 2025 Sep 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40888855 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+JT%22">Wu JT</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Nowak+E%22">Nowak E</searchLink>; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Imamura+J%22">Imamura J</searchLink>; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Leng+J%22">Leng J</searchLink>; Case Western Reserve University School of Medicine, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+D%22">Shepard D</searchLink>; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+SR%22">Campbell SR</searchLink>; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Scott+J%22">Scott J</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Nystrom+L%22">Nystrom L</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mesko+N%22">Mesko N</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Schwartz+GK%22">Schwartz GK</searchLink>; Case Comprehensive Cancer Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Burke+ZDC%22">Burke ZDC</searchLink>; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. burkez@ccf.org.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100900946%22">Current treatment options in oncology</searchLink> [Curr Treat Options Oncol] 2025 Oct; Vol. 26 (10), pp. 891-909. <i>Date of Electronic Publication: </i>2025 Sep 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%2C+Inc%22">Current Science, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100900946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-6277 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215346277%22">15346277 </searchLink><i>NLM ISO Abbreviation: </i>Curr Treat Options Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40888855 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11864-025-01349-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 891 Titles: – TitleFull: Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu JT – PersonEntity: Name: NameFull: Nowak E – PersonEntity: Name: NameFull: Imamura J – PersonEntity: Name: NameFull: Leng J – PersonEntity: Name: NameFull: Shepard D – PersonEntity: Name: NameFull: Campbell SR – PersonEntity: Name: NameFull: Scott J – PersonEntity: Name: NameFull: Nystrom L – PersonEntity: Name: NameFull: Mesko N – PersonEntity: Name: NameFull: Schwartz GK – PersonEntity: Name: NameFull: Burke ZDC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1534-6277 Numbering: – Type: volume Value: 26 – Type: issue Value: 10 Titles: – TitleFull: Current treatment options in oncology Type: main |
| ResultId | 1 |